CNS pipeline · person
Sergio Traversa, PharmD, MBA
Chief Executive Officer and a Director of Relmada Therapeutics since April 2012. He has over 25 years of experience in the healthcare sector across the United States and Europe; earlier roles included positions at Eli Lilly (where he worked on the launch of Prozac and the early development of Zyprexa and Cymbalta) and Johnson & Johnson's Therakos division. He holds a Laurea in Pharmacy from the University of Turin and an MBA in finance and international business from New York University.
- 1 company
Courtesy Relmada Therapeutics
Current roles
- Relmada Therapeutics, Inc.Chief Executive Officer · Executive2012–present
- Relmada Therapeutics, Inc.Director · Board2012–present
Appears with
People sharing a company with Sergio.
- Charles Ence · Relmada Therapeutics, Inc.
- Charles J. Casamento · Relmada Therapeutics, Inc.
- Fabiana Fedeli · Relmada Therapeutics, Inc.
- John Glasspool · Relmada Therapeutics, Inc.
- Maged Shenouda · Relmada Therapeutics, Inc.
- Max Kates · Relmada Therapeutics, Inc.
- Paul Kelly · Relmada Therapeutics, Inc.
- Raj S. Pruthi · Relmada Therapeutics, Inc.
- Yair Lotan · Relmada Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.